Net profit of J B Chemicals & Pharmaceuticals rose 15.92% to Rs 174.57 crore in the quarter ended September 2024 as against Rs 150.59 crore during the previous quarter ended September 2023. Sales rose 13.48% to Rs 1000.62 crore in the quarter ended September 2024 as against Rs 881.74 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales1000.62881.74 13 OPM %27.0427.62 - PBDT278.41240.83 16 PBT236.53208.66 13 NP174.57150.59 16 Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6 November 2024Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals has allotted 69,850 equity shares under ESOS on 26 August 2024. Consequently, the issued, subscribed and paid up capital has increased from 15,52,24,558 equity shares of Re. 1 each to 15,52,94,408 equity shares of Re. 1 each.Powered by Capital Market - Live News

Net profit of J B Chemicals & Pharmaceuticals rose 24.25% to Rs 176.83 crore in the quarter ended June 2024 as against Rs 142.32 crore during the previous quarter ended June 2023. Sales rose 12.07% to Rs 1004.40 crore in the quarter ended June 2024 as against Rs 896.20 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales1004.40896.20 12 OPM %27.9125.90 - PBDT280.62225.68 24 PBT239.84194.30 23 NP176.83142.32 24 Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals has allotted 11,500 equity shares under ESOS on 08 August 2024. Consequently, the issued, subscribed and paid up capital has increased from 155,213,058 equity shares of Re. 1 each to 155,224,558 equity shares of Re. 1 each. Powered by Capital Market - Live News